| 产品名称 | Peptides EP11422_1 | Survivin 96-104 (HLA-A*02:01) |
|---|---|
| 目录号 | EP11422_1 |
| 别名 | Survivin 96-104 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP11422_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP11422_1 | Survivin 96-104 (HLA-A*02:01)
品名：Survivin 96-104 (HLA-A*02:01)
货号：EP11422_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of anti-Survivin T cell receptor (TCR) is constructed for the engineering of T cell to target Human Survivin. The T cells are genetically modified through transduction with a retroviral vector expressing Survivin-specific T cell receptor. And the vector product was designed for the treatment of diseases involving malignant cells expressing survivin.
| Protein | Survivin |
| Species | Human |
| Application | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication | Cancer |
